Vanda Pharmaceuticals Inc.·4

Feb 26, 4:46 PM ET

Polymeropoulos Mihael Hristos 4

4 · Vanda Pharmaceuticals Inc. · Filed Feb 26, 2025

Insider Transaction Report

Form 4
Period: 2025-02-26
Polymeropoulos Mihael Hristos
DirectorPresident and CEOOther
Transactions
  • Purchase

    Common Stock

    2025-02-26$4.75/sh+5,000$23,7502,336,730 total
  • Purchase

    Common Stock

    2025-02-26$4.78/sh+5,000$23,9002,341,730 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4